VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,230,000 | -27.0% | 328,600 | -4.6% | 0.73% | -36.9% |
| Q4 2017 | $7,165,000 | +62.4% | 344,300 | +35.7% | 1.16% | +34.0% |
| Q2 2017 | $4,413,000 | +1716.0% | 253,800 | +2463.6% | 0.86% | +1248.4% |
| Q3 2016 | $243,000 | +45.5% | 9,900 | +19.7% | 0.06% | +30.6% |
| Q2 2016 | $167,000 | -23.0% | 8,270 | 0.0% | 0.05% | -33.8% |
| Q1 2016 | $217,000 | -74.0% | 8,270 | 0.0% | 0.07% | -76.7% |
| Q4 2015 | $836,000 | -47.3% | 8,270 | -6.8% | 0.32% | -40.6% |
| Q3 2015 | $1,585,000 | -19.5% | 8,870 | 0.0% | 0.54% | -10.2% |
| Q2 2015 | $1,968,000 | +37.1% | 8,870 | +22.0% | 0.60% | +61.5% |
| Q1 2015 | $1,435,000 | +73.7% | 7,270 | +26.0% | 0.37% | +73.2% |
| Q4 2014 | $826,000 | +105.5% | 5,770 | +87.9% | 0.21% | +66.4% |
| Q3 2014 | $402,000 | -79.8% | 3,070 | -80.5% | 0.13% | -71.7% |
| Q2 2014 | $1,994,000 | -16.1% | 15,770 | -12.7% | 0.45% | -32.1% |
| Q1 2014 | $2,378,000 | -12.2% | 18,070 | -21.7% | 0.67% | -15.8% |
| Q4 2013 | $2,707,000 | +7.1% | 23,070 | -4.9% | 0.79% | +5.3% |
| Q3 2013 | $2,527,000 | +72.6% | 24,270 | +43.0% | 0.75% | +57.0% |
| Q2 2013 | $1,464,000 | – | 16,970 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |